Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

MLA

Instituto de Salud Carlos III, et al. Autologous Patient-Derived Exhausted Nano T-Cells Exploit Tumor Immune Evasion to Engage an Effective Cancer Therapy. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442729279&authtype=sso&custid=ns315887.

APA

Instituto de Salud Carlos III, Junta de Andalucía, Ministerio de Ciencia e Innovación (España), European Commission, Blaya-Cánovas, J. L., Griñán-Lisón, C., Blancas, I., Marchal, J. A., Ramírez-Tortosa, C., López-Tejada, A., Benabdellah, K., Cortijo-Gutiérrez, M., Cano-Cortés, M. V., Graván, P., Navarro-Marchal, S. A., Gómez-Morales, J., Delgado-Almenta, V., Calahorra, J., Agudo-Lera, M., … Granados-Principal, S. (2024). Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.

Chicago

Instituto de Salud Carlos III, Junta de Andalucía, Ministerio de Ciencia e Innovación (España), European Commission, José L. Blaya-Cánovas, Carmen Griñán-Lisón, Isabel Blancas, et al. 2024. “Autologous Patient-Derived Exhausted Nano T-Cells Exploit Tumor Immune Evasion to Engage an Effective Cancer Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442729279&authtype=sso&custid=ns315887.